About the AACR - Leading Discoveries Magazine

Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 50,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 129 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops–the largest of which is the AACR Annual Meeting, with more than 74,000 attendees for the 2020 virtual meetings and more than 22,500 attendees for past in-person meetings. In addition, the AACR publishes 10 prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.

AACR Officers

CHIEF EXECUTIVE OFFICER
Margaret Foti, PhD, MD (hc)
American Association for Cancer Research, Philadelphia, Pennsylvania

PRESIDENT
Lisa M. Coussens, PhD, FAACR (2022-2023)
Hildegard Lamfrom Endowed Chair in Basic Science, Chair, Department of Cell, Developmental & Cancer Biology, Associate Director for Basic Research, OHSU Knight Cancer Institute, Oregon Health & Science University School of Medicine, Portland, Oregon

PRESIDENT-ELECT
Philip D. Greenberg, MD, FAACR (2022-2023)
The Rona Jaffe Foundation Endowed Chair, Professor and Head, Program in Immunology, Fred Hutchinson Cancer Research Center, Professor, Medicine and Immunology, University of Washington School of Medicine, Seattle, Washington

IMMEDIATE PAST PRESIDENT
David A. Tuveson, MD, PhD, FAACR (2022-2023)
Director and Roy J. Zuckerberg Professor of Cancer Research, Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, New York

TREASURER
William N. Hait, MD, PhD, FAACR (2022-2025)
Executive Vice President, Chief External Innovation, Medical Safety, and Global Public Health Officer
Johnson & Johnson, New Brunswick, New Jersey

TREASURER-ELECT
Michael A. Caligiuri, MD, FAACR (2022-2025)
President, City of Hope National Medical Center, Deana and Steve Campbell Physician-in-Chief Distinguished Chair, Duarte, California

AACR Directors

Nina Bhardwaj, MD, PhD (2021-2024)
Ward Coleman Chair in Cancer Research, Director of Immunotherapy, Medical Director, Vaccine and Cell Therapy Laboratory, Co-Director, Cancer Immunology Program, The Tisch Cancer Institute, Icahn School of Medicine at Mt. Sinai, New York, New York

John D. Carpten, PhD, FAACR (2022-2025)
Professor and Chair, Department of Translational Genomics, Royce and Mary Trotter Chair in Cancer Research, Professor, Department of Urology, Co-Director, Institute for Translational Genomics, Director, USC Molecular Genomics Core, Co-Leader, NCCC Translational and Clinical Sciences Program, Principal Investigator, CaRE2 Health Equity Center at USC, USC Keck School of Medicine, Los Angeles, California

Christina Curtis, PhD, MSc (2022-2025)
Associate Professor and Endowed Scholar, Departments of Medicine and Genetics, Stanford University, Director, Breast Cancer Translational Research, Co-Director, Molecular Tumor Board, Stanford Cancer Institute, Stanford, California

Luis Alberto Diaz, Jr., MD (2021-2024)
Grayer Family Chair, Head, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York

Silvia Chiara Formenti, MD (2020-2023)
Sandra and Edward Meyer Professor of Cancer Research, Professor and Chairman, Department of Radiation Oncology, Weill Cornell Medicine, Associate Director, Sandra and Edward Meyer Cancer Center, Radiation Oncologist-in-Chief, NewYork-Presbyterian Hospital, New York, New York

Elaine Fuchs, PhD, FAACR (2020-2023)
Rebecca C. Lancefield Professor and Investigator, Howard Hughes Medical Institute, The Rockefeller University, New York, New York

Susan M. Galbraith, MBBChir, PhD, MRCP, FRCR, FMedSci (2021-2024)
Executive Vice President, Oncology R&D, AstraZeneca, Cambridge, England

Roy S. Herbst, MD, PhD (2020-2023)
Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut

Thomas J. Lynch, Jr., MD (2021-2024)
President and Director, Raisbeck Endowed Chair, Fred Hutchinson Cancer Research Center, Seattle, Washington

Ira Mellman, PhD (2020-2023)
Vice President, Cancer Immunology, Genentech Inc., South San Francisco, California

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO (2021-2024)
Chief, Section of Breast Surgery, NewYork-Presbyterian/Weill Cornell Medical Center, Leader, Multidisciplinary Breast Oncology Programs, NewYork-Presbyterian David H. Koch Center, Weill Cornell Medicine, New York, New York

William Pao, MD, PhD (2022-2025)
Chief Development Officer, Executive Vice President, Pfizer, Inc., New York, New York

Kimberly Stegmaier, MD (2022-2025)
Professor of Pediatrics, Harvard Medical School, Ted Williams Investigator, Dana-Farber Cancer Institute, Boston, Massachusetts

Suzanne L. Topalian, MD (2020-2023)
Professor of Surgery and Oncology, Associate Director, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Director, Melanoma Program, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

Robert H. Vonderheide, MD, DPhil (2022-2025)
Director, Abramson Cancer Center, Vice Dean and Vice President of Cancer Programs, Perelman School of Medicine and the University of Pennsylvania Health System, Philadelphia, Pennsylvania